Alexis Bayudan
Internal Medicine · San Francisco, CANPI 1467972158
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (48.1%), food and beverage and grants — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Boston Scientific at 53.3% of the total. Reporting peaked in 2023 at $3,791 and has fallen 69.5% since, to $1,156 in 2025. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 72 payments — averaging $88.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Cook Incorporated$974
- Wilson Cook Medical Incorporated$602
- Gilead$371
- AbbVie$345
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$210
- plus $468 from 7 others
What the payments were for
- Grants$97415%
- Travel & lodging$3,05848%
- Food & beverage$2,32237%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 24 | $3,383 |
| Cook Incorporated | 1 | $974 |
| Wilson Cook Medical Incorporated | 3 | $602 |
| Gilead | 20 | $371 |
| AbbVie | 10 | $345 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $210 |
| Phathom Pharmaceuticals, Inc. | 2 | $146 |
| Johnson & Johnson | 1 | $115 |
| Olympus America Inc. | 1 | $88 |
| Pfizer | 2 | $46 |
| Braintree Laboratories, Inc. | 1 | $29 |
| Medtronic | 1 | $24 |
| Madrigal Pharmaceuticals | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,354 in reported general payments places this provider in the 90th percentile of 13,581 internal medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 32 | $502 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 22 | $374 |
| Pantoprazole Sodium | 34 | $291 |
| Ciprofloxacin Hcl | 31 | $108 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in San Francisco
- Fred CohenSan Francisco$929K
- John TeerlinkSan Francisco$819K
- Mark SmithSan Francisco$535K
- Lisa CapaldiniSan Francisco$434K
- Maria Dall'eraSan Francisco$417K
- Kenneth ColleySan Francisco$397K
- Louis CubbaSan Francisco$351K
- Daniel ButlerSan Francisco$347K
- Laurence CorashSan Francisco$336K
- Felicia StermanSan Francisco$298K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.